Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 0 | 0 | 0 | 0 | 19,520 |
| Gross Profit | N/A | N/A | N/A | N/A | 19,520 |
| Operating Expenses | 5,062 | 2,908 | 1,759 | -54,897 | 31,327 |
| Operating Income | -5,062 | -2,908 | -1,759 | 13,386 | -11,807 |
| Interest Expense | 1,237 | 971 | 805 | 0 | 0 |
| Other Income | -476 | -293 | 28 | 25,264 | 1,055 |
| Pre-tax Income | -6,775 | -4,172 | -2,536 | 38,650 | -10,752 |
| Net Income Continuous | -6,775 | -4,172 | -2,536 | 38,650 | -10,752 |
| Net Income | $-6,775 | $-4,172 | $-2,536 | $38,650 | $-10,752 |
| EPS Basic Total Ops | -3.94 | -2.47 | -1.54 | 21.41 | -8.70 |
| EPS Basic Continuous Ops | -3.83 | -2.36 | -1.43 | 29.79 | -8.70 |
| EPS Diluted Total Ops | -3.94 | -2.47 | -1.54 | 21.40 | -8.70 |
| EPS Diluted Continuous Ops | -3.83 | -2.36 | -1.43 | 29.66 | -8.70 |
| EPS Diluted Before Non-Recurring Items | -2.19 | -2.76 | -3.95 | N/A | N/A |
| EBITDA(a) | $-5,062 | $-2,908 | $-1,759 | $54,897 | $-11,068 |